Trials / Completed
CompletedNCT05723627
Comparison of Remimazolam and Propofol Effect on Oxygenation Reservoir During Diagnostic Gastric Endoscopy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Propofol is one of the most commonly used sedative in endoscopic procedures, while its potency to induce respiratory depression may threaten patient safety. Remimazolam is known to less likely induce hemodynamic instability when compared to propofol, yet its favorable effects are not clearly evaluated in endoscopic procedures. Hence, this study aimed to compare hemodynamic effects of remimazolam and propofol, by evaluating oxygen reserve index (ORI) in patients scheduled for diagnostic gastric endoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam besylate | Patients in this group receives 0.1mg/kg of remimazolam to induce sedation prior to endoscope insertion. |
| DRUG | Propofol | Patients in this group receives 0.5mg/kg of propofol to induce sedation prior to endoscope insertion. |
Timeline
- Start date
- 2023-04-06
- Primary completion
- 2023-09-21
- Completion
- 2023-09-21
- First posted
- 2023-02-13
- Last updated
- 2023-12-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05723627. Inclusion in this directory is not an endorsement.